4133 patients with heart failure and preserved ejection fraction enrolled in the I-PRESERVE trial
The baseline characteristics of the 4133 patients in the I-PRESERVE trial are broadly representative of real-world patients with HFpEF.
Patients in I-PRESERVE are broadly representative of those seen in epidemiological studies and, because of this, the results of this trial should be generally applicable to "real world" patients with heart failure and preserved ejection fraction.
Building similarity graph...
Analyzing shared references across papers
Loading...
John J.V. McMurray
British Heart Foundation
Peter E. Carson
University of North Carolina at Chapel Hill
Michel Komajda
Heart Failure & Transplant
European Journal of Heart Failure
Sorbonne Université
McMaster University
University of Glasgow
Building similarity graph...
Analyzing shared references across papers
Loading...
McMurray et al. (Fri,) studied this question.
synapsesocial.com/papers/69d7a14c1f14cb2b27b8a4c0 — DOI: https://doi.org/10.1016/j.ejheart.2007.12.010
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: